Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perhexilene metabolic support for myocardial protection during coronary artery bypass surgery
2006-003164-62Phase 3Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of piroxicam-beta-cyclodextrin in coronary arteriosclerosis (2 arms), sponsored by University Hospitals Birmingham. Primary endpoint: Incidence of low cardiac output syndrome after surgery. Started Oct 2006; status: completed.
02
Drugs
piroxicam-beta-cyclodextrin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-003164-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003164-62.